4206 Call Field Rd Wichita Falls, TX, 76308 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

5450 Knoll North Drive Columbia, MD, 21045 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

1000 East James Street Baytown, TX, 77520 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

5208 Calhoun Memorial Highway Suite C Easley, SC, 29640 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

5301 W Lovers Lane #109 Dallas, TX, 75209 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

2425 Cedar Springs Road Dallas, TX, 75201 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

2425 Cedar Springs Road Dallas, Texas, 75201 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.

5301 W Lovers Lane #109 Dallas, Texas, 75209 United StatesAccess diverse, multi-therapeutic human biospecimens—without the delays of traditional clinical trials. From infectious diseases to Alzheimer’s and beyond, Vexillum provides ready-to-ship inventory and rapid, customized collection programs. IRB-approved, globally scalable, and built for speed—so your research timelines stay on track. Vexillum, LLC, a subsidiary of KUR Research, is a trusted biospecimen partner to pharmaceutical, biotechnology, and diagnostic organizations seeking speed, reliability, and flexibility. Our multi-therapeutic biobank spans infectious diseases, neurodegenerative disorders (including Alzheimer’s disease), and a broad range of specialty indications—delivering timely access to high-quality, research-ready human samples. Core Capabilities: Rapid access to diverse biospecimens across multiple disease areas Prospective collection programs with fast startup timelines Broad specimen types: whole blood, serum, plasma, saliva, nasal and nasopharyngeal swabs, vaginal swabs, urine, and more Sourcing of healthy controls and hard-to-find patient populations Scalable site network including urgent care centers and private practices Vexillum currently holds numerous *infectious disease* biospecimens including *SARS-CoV-2*, *Influenza A*, and *Influenza B*. Our diverse site list allows us to easily collect *healthy control* samples for all your *research and development* needs. Not finding what you need in our banked specimens? Vexillum can easily begin a *biospecimen collection* to accommodate your specific needs. Our collection sites are *IRB approved* and ready to collect immediately. Vexillum protocol allows for the collection of various *Human Biospecimens* including *saliva*, *whole blood*, *serum*, *plasma*, *vaginal swabs*, *anterior nasal swabs*, *nasopharyngeal swabs*, *urine* and many more. A key demonstration of our execution capabilities includes the successful prospective collection of 1,000 donors with suspected acute upper respiratory infections within just 90 days. This was accomplished through a hybrid recruitment model integrating all-comers enrollment with targeted enrichment via standard-of-care rapid antigen testing, across KUR-affiliated urgent care centers and multidisciplinary private practices. What sets Vexillum apart? Speed and execution. We eliminate the bottlenecks of traditional procurement by offering both ready-to-ship banked specimens and fully customizable prospective collections through our pre-qualified, IRB-approved site network. All samples available for purchase are collected by trained and delegated clinical research staff utilizing an *IRB approved* protocol for specimen procurement. Each donor signs *IRB approved Informed Consent* prior to donation. Let us know how we can support your *research*, Vexillum is *making progress possible*.